Danan G, Benichou C
International Drug Safety Department, Roussel UCLAF, Paris, France.
J Clin Epidemiol. 1993 Nov;46(11):1323-30. doi: 10.1016/0895-4356(93)90101-6.
Despite the great number of methods proposed, assessing the causal role of a drug in the occurrence of an adverse medical event remains one of the most controversial issues. Qualifying terms for criteria, such as "compatible", "suggestive" of "inconclusive", have never been strictly defined, leading to low reproducibility. Weights of the criteria are usually not adapted to the injured organ, decreasing the specificity of the method. In this paper, a new method for drug causality assessment is described. Contents and limits of the criteria have been defined by experts convened to organ-oriented international consensus meetings. Additional criteria have been introduced and weights attributed. The method was applied to reports of acute liver injuries. The reproducibility was tested by an independent team. The validity of this novel method is studied in the following paper, based on an original approach using reports with positive rechallenge as external standard.
尽管已经提出了大量方法,但评估药物在不良医疗事件发生中的因果作用仍然是最具争议的问题之一。诸如“相符”“提示”“无定论”等标准的限定术语从未得到严格定义,导致可重复性较低。标准的权重通常未根据受损器官进行调整,降低了该方法的特异性。本文描述了一种新的药物因果关系评估方法。标准的内容和局限性由召集参加以器官为导向的国际共识会议的专家确定。引入了额外的标准并赋予了权重。该方法应用于急性肝损伤报告。由一个独立团队测试了其可重复性。在接下来的论文中,基于一种使用再次激发阳性报告作为外部标准的原始方法,研究了这种新方法的有效性。